These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 3744925

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers.
    Coleman CN.
    Semin Oncol; 1989 Jun; 16(3):169-75. PubMed ID: 2658080
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sensitizers and protectors in clinical oncology.
    Phillips TL.
    Semin Oncol; 1981 Mar; 8(1):65-82. PubMed ID: 6264627
    [No Abstract] [Full Text] [Related]

  • 5. Radiosensitizers: a conference preview.
    Adams GE.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1181-4. PubMed ID: 6236183
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The use of radioimmunotherapy in combination with bioreductive agents.
    Langmuir VK.
    Recent Results Cancer Res; 1996 Aug; 141():137-43. PubMed ID: 8722424
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Opportunities for improving photon radiotherapy.
    Phillips TL.
    Hosp Pract (Off Ed); 1985 Aug 15; 20(8):55-65. PubMed ID: 3926792
    [No Abstract] [Full Text] [Related]

  • 10. Chemical modification of radiation and chemotherapy.
    Brown JM, Hall EJ, Hirst DG, Kinsella TJ, Kligerman MM, Mitchell JB, Travis EJ, Valeriote F.
    Am J Clin Oncol; 1988 Jun 15; 11(3):288-303. PubMed ID: 3289362
    [No Abstract] [Full Text] [Related]

  • 11. [The role of radiotherapy in the treatment of lung cancer].
    Van Houtte P.
    Rev Med Brux; 1985 Jun 15; 6(6):397-403. PubMed ID: 4035139
    [No Abstract] [Full Text] [Related]

  • 12. Hypoxia-mediated radiation and chemo-sensitizing drugs.
    Adams GE.
    Br J Cancer; 1984 Sep 15; 50(3):285-9. PubMed ID: 6466542
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 1977 Henry H. Janeway lecture: fundamental mechanisms in combined modality therapy of cancer.
    Kaplan HS.
    AJR Am J Roentgenol; 1977 Sep 15; 129(3):383-93. PubMed ID: 409189
    [No Abstract] [Full Text] [Related]

  • 15. Chemical modifiers of cancer treatment.
    Phillips TL.
    Int J Radiat Oncol Biol Phys; 1984 Sep 15; 10(9):1791-4. PubMed ID: 6480462
    [Abstract] [Full Text] [Related]

  • 16. Biology-based combined-modality radiotherapy: workshop report.
    Mason KA, Komaki R, Cox JD, Milas L.
    Int J Radiat Oncol Biol Phys; 2001 Jul 15; 50(4):1079-89. PubMed ID: 11429236
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Radiation Modifiers.
    Citrin DE.
    Hematol Oncol Clin North Am; 2019 Dec 15; 33(6):1041-1055. PubMed ID: 31668205
    [Abstract] [Full Text] [Related]

  • 19. Chemical radiation sensitizers and protectors: recent developments.
    Kim JH, Chu FC.
    Clin Bull; 1981 Dec 15; 11(1):5-11. PubMed ID: 6268335
    [No Abstract] [Full Text] [Related]

  • 20. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
    Yuhas JM, Yurconic M, Kligerman MM, West G, Peterson DF.
    Radiat Res; 1977 May 15; 70(2):433-43. PubMed ID: 193145
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.